Insider Transactions in Q4 2022 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 30
2022
|
Legorreta Pablo G. CEO, Chairman of the Board |
BUY
Bona fide gift
|
Indirect |
292,190
+50.0%
|
-
|
Dec 30
2022
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
943
+2.72%
|
$36,777
$39.76 P/Share
|
Dec 30
2022
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
943
+3.26%
|
$36,777
$39.76 P/Share
|
Dec 09
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
19,990
-12.76%
|
$839,580
$42.07 P/Share
|
Dec 05
2022
|
Mario Germano Giuliani |
SELL
Open market or private sale
|
Indirect |
84,302
-1.07%
|
$3,624,986
$43.15 P/Share
|
Dec 02
2022
|
Mario Germano Giuliani |
SELL
Open market or private sale
|
Indirect |
197,766
-2.45%
|
$8,503,938
$43.98 P/Share
|
Dec 01
2022
|
Mario Germano Giuliani |
SELL
Open market or private sale
|
Indirect |
165,000
-0.74%
|
$7,260,000
$44.1 P/Share
|
Nov 22
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
16,369
-5.28%
|
$703,867
$43.16 P/Share
|
Nov 21
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
23,631
-6.66%
|
$1,016,133
$43.11 P/Share
|
Nov 17
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
120,000
-43.37%
|
$5,040,000
$42.33 P/Share
|
Nov 10
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
50,000
-9.87%
|
$2,150,000
$43.85 P/Share
|
Nov 08
2022
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
24,500
-2.54%
|
$1,053,500
$43.47 P/Share
|
Nov 02
2022
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
5,500
-0.57%
|
$236,500
$43.06 P/Share
|